Intersect ENT, Inc. provided sales guidance for the fourth quarter and year ended December 31, 2016 and for the first quarter and full year of 2017. For the fourth quarter, revenue is expected to be in the range of $24.0 million to $24.2 million. For the full year 2016 revenue is expected to be in the range of $78.5 million to $78.7 million. The company forecasts 2017 revenue of approximately $87-89 million and first quarter revenue of $19 million - $19.5 million.